Par Drugs (India) Today
| PAR Stock | 281.45 3.05 1.07% |
Performance17 of 100
| Odds Of DistressLess than 9
|
Par Drugs is trading at 281.45 as of the 25th of April 2024, a -1.07 percent decrease since the beginning of the trading day. The stock's lowest day price was 277.7. Par Drugs has less than a 9 % chance of experiencing financial distress in the next few years and had a solid performance during the last 90 days. Equity ratings for Par Drugs And are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 6th of May 2022 and ending today, the 25th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Par Drugs is entity of India. It is traded as Stock on NSE exchange. The company has 12.3 M outstanding shares. More on Par Drugs And
Moving together with Par Stock
| 0.78 | INDIGO | InterGlobe Aviation Earnings Call Tomorrow | PairCorr |
| 0.68 | INSPIRISYS | Inspirisys Solutions | PairCorr |
Moving against Par Stock
| 0.55 | KEEPLEARN | DSJ Keep Learning | PairCorr |
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Par Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Par Drugs' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Par Drugs or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | Drugs (View all Themes) |
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Drugs, Health Care, Pharmaceuticals, Drug Manufacturers-Specialty & Generic, Healthcare (View all Sectors) |
Par Drugs And (PAR) is traded on National Stock Exchange of India in India and employs 105 people. Par Drugs is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.5 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Par Drugs's market, we take the total number of its shares issued and multiply it by Par Drugs's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Par Drugs And operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 12.3 M outstanding shares.
Par Drugs generates positive cash flow from operations, but has no cash available
Check Par Drugs Probability Of Bankruptcy
Par Stock Price Odds Analysis
What are Par Drugs' target price odds to finish over the current price? Based on a normal probability distribution, the odds of Par Drugs jumping above the current price in 90 days from now is near 1%. The Par Drugs And probability density function shows the probability of Par Drugs stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Par Drugs And has a beta of -1.0431 indicating Additionally, par Drugs And has an alpha of 0.546, implying that it can generate a 0.55 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Par Drugs to move above the current price in 90 days from now is near 1 (This Par Drugs And probability density function shows the probability of Par Stock to fall within a particular range of prices over 90 days) .
Par Drugs And Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Par Drugs market risk premium is the additional return an investor will receive from holding Par Drugs long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Par Drugs. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Par Drugs' alpha and beta are two of the key measurements used to evaluate Par Drugs' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.12 | |||
| Semi Deviation | 1.86 | |||
| Standard Deviation | 2.61 | |||
| Variance | 6.79 |
Par Stock Against Markets
Picking the right benchmark for Par Drugs stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Par Drugs stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Par Drugs is critical whether you are bullish or bearish towards Par Drugs And at a given time. Please also check how Par Drugs' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Par Drugs without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Rebalancing Now
Portfolio RebalancingAnalyze risk-adjusted returns against different time horizons to find asset-allocation targets |
| All Next | Launch Module |
Par Drugs Corporate Management
Elected by the shareholders, the Par Drugs' board of directors comprises two types of representatives: Par Drugs inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Par. The board's role is to monitor Par Drugs' management team and ensure that shareholders' interests are well served. Par Drugs' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Par Drugs' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jignesh Savani | CEO Director | Profile | |
| Chintan Chauhan | Chief Officer | Profile | |
| Ghanshayambhai Savani | Whole Director | Profile | |
| Sanket Trivedi | Company Officer | Profile | |
| Falgun Savani | Chairman MD | Profile |
How to buy Par Stock?
Before investing in Par Drugs, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Par Drugs. To buy Par Drugs stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Par Drugs. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Par Drugs stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Par Drugs And stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Par Drugs And stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Par Drugs And, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Par Drugs And?
The danger of trading Par Drugs And is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Par Drugs is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Par Drugs. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Par Drugs And is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Par Drugs And. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Complementary Tools for Par Stock analysis
When running Par Drugs' price analysis, check to measure Par Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Par Drugs is operating at the current time. Most of Par Drugs' value examination focuses on studying past and present price action to predict the probability of Par Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Par Drugs' price. Additionally, you may evaluate how the addition of Par Drugs to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |